Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Rolf Gedeborg, Lars Lindhagen, Stacy Loeb, Johan Styrke, Hans Garmo & Pär Stattin. (2022) Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer. Scandinavian Journal of Urology 56:2, pages 104-111.
Read now
Read now
Karl-Johan Lundström, Hans Garmo, Rolf Gedeborg, Pär Stattin & Johan Styrke. (2021) Short-term ciprofloxacin prophylaxis for prostate biopsy and risk of aortic aneurysm. Nationwide, population-based cohort study. Scandinavian Journal of Urology 55:3, pages 221-226.
Read now
Read now
Gincy George, Hanna Vikman, Rolf Gedeborg, Ingela Franck Lissbrant, Hans Garmo, Johan Styrke, Mieke Van Hemelrijck & Pär Stattin. (2021) Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden. Acta Oncologica 60:4, pages 459-465.
Read now
Read now
Ingela Franck Lissbrant, Marie Hjälm Eriksson, Mats Lambe, Magnus Törnblom & Pär Stattin. (2020) Set-up and preliminary results from the Patient-overview Prostate Cancer. Longitudinal registration of treatment of advanced prostate cancer in the National Prostate Cancer Register of Sweden. Scandinavian Journal of Urology 54:3, pages 227-234.
Read now
Read now
Gincy George, Hans Garmo, Sarah Rudman, Lars Holmberg, David Robinson, Pär Stattin, Jan Adolfsson & Mieke Van Hemelrijck. (2020) Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base Sweden. Scandinavian Journal of Urology 54:1, pages 20-26.
Read now
Read now
Olof Sjöström, Gustav Silander, Ingvar Syk, Roger Henriksson, Beatrice Melin & Barbro N. Hellquist. (2018) Disparities in colorectal cancer between Northern and SouthernSweden – a report from the new RISK North database. Acta Oncologica 57:12, pages 1622-1630.
Read now
Read now
JT Helgstrand, N Klemann, MA Røder, BG Toft, K Brasso, B Vainer & P Iversen. (2016) Danish Prostate Cancer Registry – methodology and early results from a novel national database. Clinical Epidemiology 8, pages 351-360.
Read now
Read now
Kristin Andersson, Freddie Bray, Marc Arbyn, Hans Storm, Roberto Zanetti, Göran Hallmans, Jan W. Coebergh & Joakim Dillner. (2010) The interface of population-based cancer registries and biobanks in etiological and clinical research – current and future perspectives. Acta Oncologica 49:8, pages 1227-1234.
Read now
Read now
Articles from other publishers (39)
Richard Shore, Ji Zhang, Weimin Ye, Pär Stattin & Mats Lindblad. (2023) Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study. Cancer Causes & Control.
Crossref
Crossref
Yanina Balabanova, Bahman Farahmand, Pär Stattin, Hans Garmo & Gunnar Brobert. (2022) Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden. BMC Urology 22:1.
Crossref
Crossref
Karin Braide, Jon Kindblom, Camilla Thellenberg Karlsson, Pär Stattin, Jonas Hugosson & Marianne Månsson. (2022) Risk of severe late toxicity after radiotherapy following radical prostatectomy – a nationwide study. BJU International 130:6, pages 799-808.
Crossref
Crossref
Rolf Gedeborg, Stacy Loeb, Johan Styrke, Ritva Kiiski‐Berggren, Hans Garmo & Pär Stattin. (2022)
Susceptibility to
SARS‐Cov
‐2 infection and risk for severe
COVID
‐19 in patients with prostate cancer on androgen deprivation therapy
. International Journal of Cancer 151:11, pages 1925-1934.
Crossref
Crossref
Yanina Balabanova, Bahman Farahmand, Hans Garmo, Pär Stattin & Gunnar Brobert. (2022) Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden. BMJ Open 12:5, pages e055485.
Crossref
Crossref
Johan Björklund, Pär Stattin, Erik Rönmark, Markus Aly & Olof Akre. (2021) The 90‐day cause‐specific mortality after radical prostatectomy: a nationwide population‐based study. BJU International 129:3, pages 318-324.
Crossref
Crossref
Maria Hermann, Hanna Vikman, Pär Stattin, Asmatullah Katawazai, Ove Gustafsson, Johan Styrke & Gabriel Sandblom. (2021) Androgen Deprivation Therapy and the Risk for Inguinal Hernia: An Observational Nested Case Control Study. American Journal of Men's Health 15:6, pages 155798832110586.
Crossref
Crossref
Rolf Gedeborg, Johan Styrke, Stacy Loeb, Hans Garmo & Pär Stattin. (2021) Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic. PLOS ONE 16:10, pages e0255966.
Crossref
Crossref
Rolf Gedeborg, Malin Sund, Mats Lambe, Anna Plym, Irma Fredriksson, Johan Syrjä, Lars Holmberg, David Robinson, Pär Stattin & Hans Garmo. (2021) An Aggregated Comorbidity Measure Based on History of Filled Drug Prescriptions: Development and Evaluation in Two Separate Cohorts. Epidemiology 32:4, pages 607-615.
Crossref
Crossref
Elisabeth Rasmusson, Per Nilsson, Elisabeth Kjellén & Adalsteinn Gunnlaugsson. (2021) Long-Term Risk of Hip Complications After Radiation Therapy for Prostate Cancer: A Dose-Response Study. Advances in Radiation Oncology 6:1, pages 100571.
Crossref
Crossref
Rolf Gedeborg, Hans Garmo, David Robinson & Pär Stattin. (2020) Prescription-based prediction of baseline mortality risk among older men. PLOS ONE 15:10, pages e0241439.
Crossref
Crossref
Jonathan Parker, Danielle Crawley, Hans Garmo, Bertil Lindahl, Johan Styrke, Jan Adolfsson, Mats Lambe, Pär Stattin, Mieke Van Hemelrijck & Kerri Beckmann. (2020) Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study. Frontiers in Oncology 10.
Crossref
Crossref
Renata Zelic, Hans Garmo, Daniela Zugna, Pär Stattin, Lorenzo Richiardi, Olof Akre & Andreas Pettersson. (2020) Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study. European Urology 77:2, pages 180-188.
Crossref
Crossref
Prabhakar RajanPrasanna SooriakumaranTommy NybergOlof AkreStefan CarlssonLars EgevadGunnar SteineckN. Peter Wiklund. (2017) Effect of Comorbidity on Prostate Cancer–Specific Mortality: A Prospective Observational Study. Journal of Clinical Oncology 35:31, pages 3566-3574.
Crossref
Crossref
Prasanna Sooriakumaran, Tommy Nyberg, Olof Akre, Anders Widmark, Freddie Hamdy, Markus Graefen, Stefan Carlsson, Gunnar Steineck & N. Peter Wiklund. (2017) Survival Among Men at High Risk of Disseminated Prostate Cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation Therapy. European Urology 72:3, pages 345-351.
Crossref
Crossref
Mieke Van Hemelrijck, Yasin Folkvaljon, Jan Adolfsson, Olof Akre, Lars Holmberg, Hans Garmo & Pär Stattin. (2016) Causes of death in men with localized prostate cancer: a nationwide, population-based study. BJU International 117:3, pages 507-514.
Crossref
Crossref
Hannah L. Brooke, Mats Talbäck, Anna Martling, Maria Feychting & Rickard Ljung. (2016) Socioeconomic position and incidence of colorectal cancer in the Swedish population. Cancer Epidemiology 40, pages 188-195.
Crossref
Crossref
Mette Rye Andersen & Hans H. Storm. (2015) Cancer registration, public health and the reform of the European data protection framework: Abandoning or improving European public health research?. European Journal of Cancer 51:9, pages 1028-1038.
Crossref
Crossref
Hanna Nilsson, Johan Stranne, Pär Stattin & Pär Nordin. (2014) Incidence of Groin Hernia Repair After Radical Prostatectomy. Annals of Surgery 259:6, pages 1223-1227.
Crossref
Crossref
Mieke Van Hemelrijck, Hans Garmo, Karl Michaëlsson, Andreas Thorstenson, Olof Akre, Pär Stattin, Lars Holmberg & Jan Adolfsson. (2013) Mortality following Hip Fracture in Men with Prostate Cancer. PLoS ONE 8:9, pages e74492.
Crossref
Crossref
Sara M. Wirén, Linda I. Drevin, Sigrid V. Carlsson, Olof Akre, Erik C. Holmberg, David E. Robinson, Hans G. Garmo & Pär E. Stattin. (2013) Fatherhood status and risk of prostate cancer: Nationwide, population‐based case–control study. International Journal of Cancer 133:4, pages 937-943.
Crossref
Crossref
M. Van Hemelrijck, A. Wigertz, F. Sandin, H. Garmo, K. Hellstrom, P. Fransson, A. Widmark, M. Lambe, J. Adolfsson, E. Varenhorst, J.-E. Johansson, P. Stattin, L. Drevin, A. Bill-Axelson, D. Robinson & O. Akre. (2012) Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0. International Journal of Epidemiology 42:4, pages 956-967.
Crossref
Crossref
Katja Fall, Hans Garmo, Soffia Gudbjörnsdottir, Pär Stattin & Björn Zethelius. (2013) Diabetes Mellitus and Prostate Cancer Risk; A Nationwide Case–Control Study within PCBaSe Sweden. Cancer Epidemiology, Biomarkers & Prevention 22:6, pages 1102-1109.
Crossref
Crossref
Mieke Van Hemelrijck, Hans Garmo, Lars Holmberg, Anna Bill-Axelson, Stefan Carlsson, Olof Akre, Pär Stattin & Jan Adolfsson. (2013) Thromboembolic Events Following Surgery for Prostate Cancer. European Urology 63:2, pages 354-363.
Crossref
Crossref
Stacy Loeb, Linda Drevin, David Robinson, Erik Holmberg, Sigrid Carlsson, Mats Lambe & Pär Stattin. (2012) Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based study. Cancer Causes & Control 24:2, pages 383-390.
Crossref
Crossref
Mieke Van Hemelrijck, Linda Drevin, Lars Holmberg, Hans Garmo, Jan Adolfsson & Pär Stattin. (2012) Primary cancers before and after prostate cancer diagnosis. Cancer 118:24, pages 6207-6216.
Crossref
Crossref
B. Grundmark, H. Garmo, B. Zethelius, P. Stattin, M. Lambe & L. Holmberg. (2012) Anti-androgen prescribing patterns, patient treatment adherence and influencing factors; results from the nationwide PCBaSe Sweden. European Journal of Clinical Pharmacology 68:12, pages 1619-1630.
Crossref
Crossref
K. Fredrik Jansson, Olof Akre, Hans Garmo, Anna Bill-Axelson, Jan Adolfsson, Pär Stattin & Ola Bratt. (2012) Concordance of Tumor Differentiation Among Brothers with Prostate Cancer. European Urology 62:4, pages 656-661.
Crossref
Crossref
Andreas Thorstenson, Ola Bratt, Olof Akre, Henrik Hellborg, Lars Holmberg, Mats Lambe, Anna Bill-Axelson, Pär Stattin & Jan Adolfsson. (2012) Incidence of fractures causing hospitalisation in prostate cancer patients: Results from the population-based PCBaSe Sweden. European Journal of Cancer 48:11, pages 1672-1681.
Crossref
Crossref
Mieke Van Hemelrijck, Hans Garmo, Lars Holmberg, Pär Stattin & Jan Adolfsson. (2012) Multiple Events of Fractures and Cardiovascular and Thromboembolic Disease Following Prostate Cancer Diagnosis: Results From the Population-Based PCBaSe Sweden. European Urology 61:4, pages 690-700.
Crossref
Crossref
David Robinson, Hans Garmo, Bertil Lindahl, Mieke Van Hemelrijck, Jan Adolfsson, Ola Bratt, Lars Holmberg & Pär Stattin. (2011) Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden. International Journal of Cancer 130:2, pages 478-487.
Crossref
Crossref
Anders Berglund, Hans Garmo, David Robinson, Carol Tishelman, Lars Holmberg, Ola Bratt, Jan Adolfsson, Pär Stattin & Mats Lambe. (2012) Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer. European Journal of Cancer 48:1, pages 75-84.
Crossref
Crossref
Olof Akre, Hans Garmo, Jan Adolfsson, Mats Lambe, Ola Bratt & Pär Stattin. (2011) Mortality Among Men with Locally Advanced Prostate Cancer Managed with Noncurative Intent: A Nationwide Study in PCBaSe Sweden. European Urology 60:3, pages 554-563.
Crossref
Crossref
Anna Bill-Axelson, Hans Garmo, Ullakarin Nyberg, Mats Lambe, Ola Bratt, Pär Stattin, Jan Adolfsson & Gunnar Steineck. (2011) Psychiatric treatment in men with prostate cancer – Results from a Nation-wide, population-based cohort study from PCBaSe Sweden. European Journal of Cancer 47:14, pages 2195-2201.
Crossref
Crossref
Anders Berglund, Hans Garmo, Carol Tishelman, Lars Holmberg, Pär Stattin & Mats Lambe. (2011) Comorbidity, Treatment and Mortality: A Population Based Cohort Study of Prostate Cancer in PCBaSe Sweden. Journal of Urology 185:3, pages 833-840.
Crossref
Crossref
P. Stattin, H. Garmo, G. Steineck & A. Bill-Axelson. (2010) Re: Immediate Risk of Suicide and Cardiovascular Death After a Prostate Cancer Diagnosis: Cohort Study in the United States. JNCI Journal of the National Cancer Institute 102:18, pages 1447-1448.
Crossref
Crossref
Mieke Van HemelrijckHans GarmoLars HolmbergErik IngelssonOla BrattAnna Bill-AxelsonMats LambePär StattinJan Adolfsson. (2010) Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden. Journal of Clinical Oncology 28:21, pages 3448-3456.
Crossref
Crossref
Mieke Van Hemelrijck, Jan Adolfsson, Hans Garmo, Anna Bill-Axelson, Ola Bratt, Erik Ingelsson, Mats Lambe, Pär Stattin & Lars Holmberg. (2010) Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden. The Lancet Oncology 11:5, pages 450-458.
Crossref
Crossref
Anna Bill-Axelson, Hans Garmo, Mats Lambe, Ola Bratt, Jan Adolfsson, Ullakarin Nyberg, Gunnar Steineck & Pär Stattin. (2010) Suicide Risk in Men with Prostate-Specific Antigen–Detected Early Prostate Cancer: A Nationwide Population-Based Cohort Study from PCBaSe Sweden. European Urology 57:3, pages 390-395.
Crossref
Crossref